Clinical trial
Beta-hCG + Erythropoietin in Acute Stroke
NCT00362414 · University of California, Irvine, Other · Completed
Key facts
| NCT number | NCT00362414 |
|---|---|
| Title | Beta-hCG + Erythropoietin in Acute Stroke |
| Official title | Safety of Beta-hCG + Erythropoietin in Acute Stroke |
| Acronym | BETAS |
| Lead sponsor | University of California, Irvine, Other |
| Collaborators | Stem Cell Therapeutics Corp. Industry Hoag Memorial Hospital Presbyterian |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Acute Stroke |
| Intervention type | Drug |
| Interventions | Dual Growth Factor |
| Enrollment | 15 |
| Start date | Aug 1, 2006 |
| Primary completion | Mar 1, 2008 |
| Completion | Mar 1, 2008 |
| First posted | Aug 10, 2006 |
| Last update posted | Aug 29, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: